Cover Image

A RARE CASE OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY IN 13 YEAR OLDFEMALE PATIENT-SURGICALLY MANAGED

PRASANNA PRASANNA

Abstract


Hocm is one of the causes of sudden
deaths, it is comon in the 3rd and 4th
decade,it is not comon in adolescents, but
if present, surgical resection done early is
the main mode of treatment.


Full Text:

PDF

References


Braunwald E, Lambrew CT, Rockoff

SD, Ross J Jr, Morrow AG. Idiopathic

hypertrophic subaortic stenosis. I. A

description of the disease based upon

an analysis of 64 patients. Circulation

;30:Suppl IV:IV-3–IV-119.

Maron BJ. Hypertrophic cardiomyopathy:

a systematic review. JAMA

;287: 1308-20.

Wigle ED, Sasson Z, Henderson MA,

et al. Hypertrophic cardiomyopathy: the

importance of the site and the extent of

hypertrophy: a review. Prog Cardiovasc

Dis 1985;28: 1-83.

Marian AJ, Roberts R. Recent advances

in the molecular genetics of hypertrophic

cardiomyopathy. Circulation

;92:1336-47.

Braunwald E, Seidman CE, Sigwart

U. Contemporary evaluation and management

of hypertrophic cardiomyopathy.

Circulation 2002;106:1312-6.

Epstein SE, Rosing DR. Verapamil:

its potential for causing serious complications

in patients with hypertrophic

c a r d iom yopa t h y . C i r cul a t ion

;64:437-41.

Pollick C. Muscular subaortic stenosis:

hemodynamic and clinical improvement

after disopyramide. N Engl J Med

;307: 997-9.

Morrow AG. Hypertrophic subaortic

stenosis: operative methods utilized to

relieve left ventricular outflow obstruction.

J Thorac Cardiovasc Surg

;76:423-30.

McCully RB, Nishimura RA, Tajik AJ,

Schaff HV, Danielson GK. Extent of clinical

improvement after surgical treatment of

hypertrophic obstructive cardiomyopathy.

Circulation 1996;94:467-71.

Schulte HD, Borisov K, Gams E,

Gramsch-Zabel H, Losse B, Schwartzkopff

B. Management of symptomatic hypertrophic

obstructive cardiomyopathy — longterm

results after surgical therapy. Thorac

Cardiovasc Surg 1999;47:213-8.

Fananapazir L, Epstein ND, Curiel RV,

Panza JA, Tripodi D, McAreavey D. Longterm

results of dual-chamber (DDD) pacing

in obstructive hypertrophic cardiomyopathy:

evidence for progressive symptomatic

and hemodynamic improvement

and reduction of left ventricular hypertrophy.

Circulation 1994;90:2731-42.

Nishimura RA, Trusty JM, Hayes DL, et

al. Dual-chamber pacing for hypertrophic

cardiomyopathy: a randomized, doubleblind,

crossover study. J Am Coll Cardiol

;29:435-41.

Maron BJ, Nishimura RA, McKenna

WJ, Rakowski H, Josephson ME, Kieval

RS. Assessment of permanent dualchamber

pacing as a treatment for drugrefractory

symptomatic patients with obstructive

hypertrophic cardiomyopathy: a

randomized, double-blind, crossover study

(MPATHY). Circulation 1999;99:2927-33.

Nishimura RA, Symanski JD, Hurrell

DG, Trusty JM, Hayes DL, Tajik AJ. Dualchamber

pacing for cardiomyopathies: a

clinical perspective. Mayo Clin Proc

;71:1077-87.

Ommen SR, Nishimura RA, Squires


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr MGR Medical University